Lenvatinib Rechallenge after Failure of Lenvatinib and Sorafenib in Metastatic Thyroid Cancer.
Investigational New Drugs（2024）
Key words
Thyroid cancer,Lenvatinib,Rechallenge,Sorafenib,Multikinase inhibitors,Vascular endothelial growth factor receptor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined